1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Company Analysis in Spain, June 2019

Mental Health Company Analysis in Spain, June 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

All regions

data types

  • All
    • Company Data
1-4 of 4 reports

University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Barcelona - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2018

SummaryUniversity of Barcelona is an educational university that offers bachelor’s degrees, master’s degrees and research doctoral studies.The university provides EHEA bachelor’s degree courses, ...

  • Industries : Pharmaceutical, Pathology
  • Countries : Spain
Oryzon Genomics SA (ORY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oryzon Genomics SA (ORY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryOryzon Genomics SA (Oryzon) is a clinical stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases.The company offers ...

  • Industries : Mental Health, Pathology, Medical Biotechnology
  • Countries : United States, Spain
Lysine-Specific Histone Demethylase 1A (Lysine (K)-Specific Demethylase 1 or Flavin-Containing Amine Oxidase Domain-Containing Protein 2 or EC 1.) - Pipeline Review, H1 2016

Lysine-Specific Histone Demethylase 1A (Lysine (K)-Specific Demethylase 1 or Flavin-Containing Amine Oxidase Domain-Containing Protein 2 or EC 1.) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016

Lysine-Specific Histone Demethylase 1A (Lysine (K)-Specific Demethylase 1 or Flavin-Containing Amine Oxidase Domain-Containing Protein 2 or EC 1.) - Pipeline Review, H1 2016 SummaryGlobal Markets Direct’s, ...

  • Industries : Therapy, Pathology
  • Countries : World, United States, Spain
Oryzon Genomics S.A. (ORY) - Product Pipeline Analysis, 2016 Update

Oryzon Genomics S.A. (ORY) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • April 2016

SummaryOryzon Genomics S.A. (Oryzon) is a clinical stage biopharmaceutical company that offers development of epigenetics-based therapeutics. The company offers epigenetics, a regulatory system that controls ...

  • Industries : Cancer
  • Countries : Spain


5 reports

Download Unlimited Documents from Trusted Public Sources


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on